SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,908.31 -327.15
( -0.42%)

Global Indices

Nasdaq

53,360.44 -120.34
(-0.23%)

Dow Jones

7,713.14 -52.92
(-0.68%)

Hang Seng

67,388.40 -1,831.85
(-2.65%)

Nikkei 225

10,735.70 15.40
(0.14%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Panacea Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

531349

INE922B01023

46.5684246

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PANACEABIO

2488.01

EPS(TTM)

Face Value()

Div & Yield %

Back

Asian Tea & Exports consolidated net profit declines 85.71% in the June 2026 quarter

Aug 14,2026

Net profit of Asian Tea & Exports declined 85.71% to Rs 0.04 crore in the quarter ended June 2026 as against Rs 0.28 crore during the previous quarter ended June 2025. Sales declined 21.95% to Rs 10.70 crore in the quarter ended June 2026 as against Rs 13.71 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	10.70	13.71	-22
OPM %	0.93	1.60	-
PBDT	0.16	0.37	-57
PBT	0.09	0.29	-69
NP	0.04	0.28	-86

76,908.31 -327.15 ( -0.42%)

53,360.44 -120.34 (-0.23%)

7,713.14 -52.92 (-0.68%)

67,388.40 -1,831.85 (-2.65%)

10,735.70 15.40 (0.14%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)